In today’s recent session, 121.85 million shares of the Predictive Oncology Inc (NASDAQ:POAI) have been traded, and its beta is 1.26. Most recently the company’s share price was $2.23, and it changed around $1.11 or 100.00% from the last close, which brings the market valuation of the company to $16.08M. POAI at last check was trading at a discount to its 52-week high of $3.06, offering almost -37.22% off that amount. The share price’s 52-week low was $0.55, which indicates that the recent value has risen by an impressive 75.34% since then. We note from Predictive Oncology Inc’s average daily trading volume that its 10-day average is 50270.0 shares, with the 3-month average coming to 2.20 million.
Predictive Oncology Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended POAI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Predictive Oncology Inc is expected to report earnings per share of 0 for the current quarter.
Predictive Oncology Inc (NASDAQ:POAI) trade information
Instantly POAI has been showing a green trend so far today with a performance of 100.00% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.4900 on recent trading dayincreased the stock’s daily price by 10.44%. The company’s shares are currently up 171.95% year-to-date, but still up 93.91% over the last five days. On the other hand, Predictive Oncology Inc (NASDAQ:POAI) is 59.29% up in the 30-day period. We can see from the shorts that 0.51 million shares have been sold at a short interest cover period of 1.22 day(s).
Predictive Oncology Inc (POAI) estimates and forecasts
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 350k in revenue for the current quarter. 1 analysts expect Predictive Oncology Inc to make 1.5M in revenue for the current ending quarter. Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 53.33%.
Predictive Oncology Inc (NASDAQ:POAI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.55% of Predictive Oncology Inc shares, and 3.34% of them are in the hands of institutional investors. The stock currently has a share float of 3.39%. Predictive Oncology Inc stock is held by 18.0 institutions, with ADVISORNET FINANCIAL, INC being the largest institutional investor. By 2024-06-30, it held 0.0023% of the shares, which is about 95.0 shares worth $99.0.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 69.88 shares worth $0.14 million, making up 1.02% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 34.39 shares worth around $68098.0, which represents about 0.50% of the total shares outstanding.
